This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The company’s advanced non-invasive computed tomography (CT) imaging technology enables comprehensive phenotyping of coronary artery disease, grounded in scientific research based on millions of medical images. Until Cleerly, healthcare providers have had no way to easily and completely assess plaque burden in a non-invasive manner.
THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter that integrates two critical PAD treatments into a single device. The innovative feature of the Philips catheter is that both the atherectomy and lithotripsy are laser-driven. clinical trial,” said Dr.
a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ).
The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. This restores the vessel viability and hemodynamic modulation by returning pulsatility, compliance, adaptive blood flow volume, and plaque stabilization and regression.
The Neuroguard Integrated Embolic Protection (IEP) system is an experimental treatment for carotid artery stenosis, also known as carotid artery disease, a condition in which fatty-waxy deposits known as plaque builds up and blocks the normal flow of blood in the large arteries on either side of the neck. Designed by Raleigh, N.C.
Improved patient safety with reduced radiation and contrast load Enhancing patient safety is a pivotal aspect of advanced cardiac imaging technology. By employing advanced scanning technology, healthcare providers can ensure patients undergo diagnostic procedures with minimized risks.
2-4 HeartFlow’s non-invasive FFR CT technology has emerged as a leading frontline strategy for accurately diagnosing hemodynamically significant coronary lesions in patients suspected of having CAD. Journal of Vascular Surgery Cases, Innovations and Techniques, vol. 101272, [link].
According to the company, Earls is a leader within the field of radiology and specializes in applications of advanced imaging technologies in cardiovascular care. He is the author of over 150 articles, book chapters, abstracts and other publications on advanced imaging technologies. With Plaque Features Associated with False Positives.
7 While HeartFlow was founded with FFR CT technology, the company has evolved from a single product used to assess the impact that narrowing vessels have on coronary blood flow (FFR CT Analysis), to a comprehensive suite of non-invasive technologies that build on CCTA. said John Farquhar, Chief Executive Officer at HeartFlow.
As technologies advance and methodologies evolve, two crucial tools stand out for their pivotal roles in enhancing accuracy and efficacy: Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IVUS). OCT employs light waves to capture high-resolution images, providing intricate details of vessel structures and plaque composition.
At the forefront of this quest lie the remarkable advancements in imaging technology, ushering in a new era of precision and insight. Cutting-edge Computed Tomography (CT) and Cardiac MRI technologies are transforming this domain, offering unprecedented insights into the intricate workings of the heart and vascular system.
At the forefront of this quest lie the remarkable advancements in imaging technology, ushering in a new era of precision and insight. Cutting-edge Computed Tomography (CT) and Cardiac MRI technologies are transforming this domain, offering unprecedented insights into the intricate workings of the heart and vascular system.
Why IVUS and OCT Are Vital These technologies aren't just extras; they are the ticket to enhanced diagnostic accuracy and improved patient results. IVUS reveals plaque characteristics, optimal stent usage, and vessel measurements. Regular training acts as your compass in the ever-changing world of medical innovations.
As technologies advance and methodologies evolve, two crucial tools stand out for their pivotal roles in enhancing accuracy and efficacy: Optical Coherence Tomography (OCT) and Intravascular Ultrasound (IVUS). OCT employs light waves to capture high-resolution images, providing intricate details of vessel structures and plaque composition.
ET Murphy Ballroom 4 Health 360x Registry: Scalable Workforce for Equitable Access to Point of Care Decentralized Clinical Trials Prevalence of Cardiovascular Disease and Risk Factors Among National Football League Alumni and Their Family Members: Results from the Huddle Study Hózhó (Heart Failure Optimization at Home to Improve Outcomes): A Pragmatic (..)
We hope that the anniversary contributions will help to support the college's mission and mission-focused work that empowers future leaders in the next generation of cardiovascular innovators through scholarship, mentorship and leadership development programs. “We
From breakthrough medications to innovativetechnologies, there is a lot for cardiometabolic clinicians professionals to celebrate. Clinicians now have access to new medications, innovativetechnologies, and refined clinical guidelines that empower them to provide more personalized, effective care to their patients.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content